Autoimmune diseases mean that the body is attacking its own cells. Researchers developing cancer drugs are attempting to recreate that effect. But instead of the immune system attacking itself, it will be trained to attack the tumor or the malignant cells. This is what doctors are referring to when they talk about checkpoint inhibition.
Checkpoint inhibitors are man-made antibodies that shut down key proteins on immune cells like PD-L1 – essentially halting a cancer’s ability to spread. Checkpoint inhibitors have been proven effective for certain later-stage cancers, but the genetic codes in certain people may inhibit their positive effects. In order to know if you’re a viable candidate for checkpoint inhibitors as a treatment for your later stage cancer, check with your doctor. They’ll go over your hereditary information to determine if it’s one of your best options.
Late stage lung cancer means that the disease has spread to other organs. The goal in these cases is to treat the whole body, destroying all the cancer cells. There are several options for how to approach treating stage four lung cancers.
Employing the immune system is now a viable treatment option for many more people with advanced-stage lung cancer.
The Outlook for Immunotherapy Treatment
Immunotherapy Has Changed The Game For Lung Cancer
A Much More Effective Alternative to Chemotherapy
Is Immunotherapy Right for My Lung Cancer?
What Do Checkpoint Inhibitors Do For Cancer?
The Importance Of Genetics In Late Stage Lung Cancers
Targeted Therapy for Lung Cancer
Getting Genetic Sequencing
How Checkpoint Inhibitors Work in Lung Cancer
How to Determine If Targeted Therapy Is Right for You
Combining Immunotherapy Drugs in Lung Cancer Clinical Trials
Immunotherapy for Advanced Lung Cancer
Why I'd Choose a Clinical Trial For Myself
Clinical Trials and What Statistics Really Mean
When Should I Consider Clinical Trials?
The Father of Immunotherapy Recommends Multiple Opinions